Literature DB >> 17543999

Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment.

Ian J Bristol1, Anesa Ahamad, Adam S Garden, William H Morrison, Ehab Y Hanna, Vassiliki A Papadimitrakopoulou, David I Rosenthal, K Kian Ang.   

Abstract

PURPOSE: To determine the effects of three changes in radiotherapy technique on the outcomes for patients irradiated postoperatively for maxillary sinus cancer. METHODS AND MATERIALS: The data of 146 patients treated between 1969 and 2002 were reviewed. The patients were separated into two groups according to the date of treatment. Group 1 included 90 patients treated before 1991 and Group 2 included 56 patients treated after 1991, when the three changes were implemented. The outcomes were compared between the two groups.
RESULTS: No differences were found in the 5-year overall survival, recurrence-free survival, local control, nodal control, or distant metastasis rates between the two groups (51% vs. 62%, 51% vs. 57%, 76% vs. 70%, 82% vs. 83%, and 28% vs. 17% for Groups 1 and 2, respectively). The three changes were to increase the portals to cover the base of the skull in patients with perineural invasion, reducing their risk of local recurrence; the addition of elective neck irradiation in patients with squamous or undifferentiated histologic features, improving the nodal control, distant metastasis, and recurrence-free survival rates (64% vs. 93%, 20% vs. 3%, and 45% vs. 67%, respectively; p < 0.05 for all comparisons); and improving the dose distributions within the target volume, reducing the late Grade 3-4 complication rates (34% in Group 1 vs. 8% in Group 2, p = 0.014). Multivariate analysis revealed advancing age, the need for enucleation, and positive margins as independent predictors of worse overall survival. The need for enucleation also predicted for worse local control.
CONCLUSION: The three changes in radiotherapy technique improved the outcomes for select patients as predicted. Despite these changes, little demonstrable overall improvement occurred in local control or survival for these patients and additional work must be done.

Entities:  

Mesh:

Year:  2007        PMID: 17543999     DOI: 10.1016/j.ijrobp.2007.01.032

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Fatigue following radiation therapy in nasopharyngeal cancer survivors: A dosimetric analysis incorporating patient report and observer rating.

Authors: 
Journal:  Radiother Oncol       Date:  2019-01-14       Impact factor: 6.280

2.  Recurrent maxillary sinus cancer with only adrenal metastasis.

Authors:  Hye Jung Chang; Joon-Young Hur; Kyu Yeoun Won; Boksoon Chang; Ha Yeon Lee
Journal:  Mol Clin Oncol       Date:  2017-09-20

3.  Sinonasal squamous cell carcinoma without clinical lymph node involvement : Which neck management is best?

Authors:  Pauline Castelnau-Marchand; Antonin Levy; Antoine Moya-Plana; Haïtham Mirghani; France Nguyen; Eleonor Rivin Del Campo; François Janot; Frédéric Kolb; François-Régis Ferrand; Stéphane Temam; Pierre Blanchard; Yungan Tao
Journal:  Strahlenther Onkol       Date:  2016-06-20       Impact factor: 3.621

4.  The Role of Full-Thickness Skin Grafts in Patient's Rehabilitation after Maxillectomy and Midface Defects.

Authors:  Iwona Niedzielska; Łukasz Obszyński; Michał Bąk; Damian Niedzielski
Journal:  J Clin Med       Date:  2022-06-22       Impact factor: 4.964

5.  Management of sinonasal tumors: prognostic factors and outcomes: a 10 year experience at a tertiary care hospital.

Authors:  Maliha Kazi; Sohail Awan; Montasir Junaid; Sadaf Qadeer; Nabeel Humayun Hassan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-04-07

Review 6.  Malignant neoplasms of the sinonasal tract: report of 71 patients and literature review and analysis.

Authors:  Bijan Khademi; Azadeh Moradi; Sara Hoseini; Mohammad Mohammadianpanah
Journal:  Oral Maxillofac Surg       Date:  2009-12

7.  Nose and paranasal sinus tumours: United Kingdom National Multidisciplinary Guidelines.

Authors:  V J Lund; P M Clarke; A C Swift; G W McGarry; C Kerawala; D Carnell
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

8.  Results of Treatment of Squamous Cell Carcinoma of Maxillary Sinus: A 26-Year Experience.

Authors:  M Ashraf; J Biswas; A Dam; A Bhowmick; V Sing; S Nayak
Journal:  World J Oncol       Date:  2010-02-01

9.  Navigation-Guided Transnasal Endoscopic Delineation of the Posterior Margin for Maxillary Sinus Cancers: A Preclinical Study.

Authors:  Stefano Taboni; Marco Ferrari; Michael J Daly; Harley H L Chan; Donovan Eu; Tommaso Gualtieri; Ashok R Jethwa; Axel Sahovaler; Andrew Sewell; Wael Hasan; Ilyes Berania; Jimmy Qiu; John de Almeida; Piero Nicolai; Ralph W Gilbert; Jonathan C Irish
Journal:  Front Oncol       Date:  2021-11-11       Impact factor: 6.244

10.  Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer.

Authors:  A Homma; T Sakashita; D Yoshida; R Onimaru; K Tsuchiya; F Suzuki; K Yasuda; H Hatakeyama; J Furusawa; T Mizumachi; S Kano; N Inamura; S Taki; H Shirato; S Fukuda
Journal:  Br J Cancer       Date:  2013-11-05       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.